BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25816835)

  • 1. Mucosal leishmaniasis mimicking squamous cell carcinoma in a liver transplant recipient.
    Ramos A; Múñez E; García-Domínguez J; Martinez-Ruiz R; Chicharro C; Baños I; Suarez-Massa D; Cuervas-Mons V
    Transpl Infect Dis; 2015 Jun; 17(3):488-92. PubMed ID: 25816835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal leishmaniasis of the lip: an emerging clinical form in Tunisia.
    Hammami-Ghorbel H; Ben Abda I; Badri T; Chelbi H; Fenniche S; Mokhtar I; Bouratbine A; Benmously-Mlika R; Aoun K
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1212-5. PubMed ID: 24910266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia].
    El Fékih N; Sliti N; Kharfi M; Trabelsi S; Khaled S; Fazaa B; Kamoun MR
    Med Trop (Mars); 2008 Dec; 68(6):634-6. PubMed ID: 19639835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches.
    Cruz AF; Resende RG; Albuquerque DR; de Lacerda JC; Leite CF; Ferreira Aguiar MC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):e199-e203. PubMed ID: 27234853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal leishmaniasis of the tongue caused by Leishmania infantum in an immunocompetent woman.
    Pampín Franco A; Gamo Villegas R; Caro-Gutiérrez D; López-Estebaranz JL; Pinedo F
    Int J Dermatol; 2015 Jan; 54(1):e39-41. PubMed ID: 25312835
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
    Motta AC; Arruda D; Souza CS; Foss NT
    Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 33-year-old male farmer with progressive gingival swelling and bleeding.
    Azizi T; Sadeghipour A; Roohi A; Nilipour Y
    Ann Saudi Med; 2005; 25(3):262, 270-1. PubMed ID: 16119532
    [No Abstract]   [Full Text] [Related]  

  • 8. Lip leishmaniasis: a case series with molecular identification and literature review.
    Mohammadpour I; Motazedian MH; Handjani F; Hatam GR
    BMC Infect Dis; 2017 Jan; 17(1):96. PubMed ID: 28122496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucocutaneous leishmaniasis and HIV.
    Miralles ES; Núñez M; Hilara Y; Harto A; Moreno R; Ledo A
    Dermatology; 1994; 189(3):275-7. PubMed ID: 7949483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: Leishmaniasis of the upper lip.
    Veraldi S; Bottini S; Persico MC; Lunardon L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Nov; 104(5):659-61. PubMed ID: 17656118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis.
    Brahn E; Pegues DA; Yao Q; Craft N
    J Clin Rheumatol; 2010 Apr; 16(3):125-8. PubMed ID: 20375822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
    Crovetto-Martínez R; Aguirre-Urizar JM; Orte-Aldea C; Araluce-Iturbe I; Whyte-Orozco J; Crovetto-De la Torre MA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e20-6. PubMed ID: 25442251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
    Sampaio RN; Marchán EM; Vexenat A; Tristão RJ; Marsden PD
    Mem Inst Oswaldo Cruz; 1990; 85(3):373-4. PubMed ID: 2134714
    [No Abstract]   [Full Text] [Related]  

  • 14. [Miltefosine or meglumine antimoniate in leishmaniasis].
    Joob B; Wiwanitkit V
    Medicina (B Aires); 2015; 75(2):130-1. PubMed ID: 25919881
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidetector computed tomography aspects of tracheal mucosal leishmaniasis localization.
    Viglianesi A; Di Mauro D; Petrillo G
    Jpn J Radiol; 2011 Jan; 29(1):59-62. PubMed ID: 21264663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.
    Mosimann V; Neumayr A; Hatz C; Blum JA
    Infection; 2013 Dec; 41(6):1177-82. PubMed ID: 23835701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients.
    Aliaga L; Cobo F; Mediavilla JD; Bravo J; Osuna A; Amador JM; Martín-Sánchez J; Cordero E; Navarro JM
    Medicine (Baltimore); 2003 May; 82(3):147-58. PubMed ID: 12792301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
    Garcia Bustos MF; Barrio A; Parodi C; Beckar J; Moreno S; Basombrio MA
    Medicina (B Aires); 2014; 74(5):371-7. PubMed ID: 25347898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.
    Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.